This research report describes results from an implementation science study that explored the feasibility and acceptability of administering depot medroxyprogesterone acetate-subcutaneous (DMPA-SC) among health-care providers and family planning (FP) clients in Ghana. DMPA-SC is an injectable contraceptive method that can be self-administered. The study, conducted by the Population Council through the USAID-funded Evidence Project in collaboration with the Ghana Health Service, was implemented in rural, peri-urban, and urban areas of the Ashanti and Volta regions. A total of 150 health-care providers were trained to administer DMPA-SC and to train clients on self-injection. Clients assessed as being competent self-injected under the provider’s supervision and could take two DMPA-SC doses home for future self-injections. Results indicate that DMPA-SC self-injection is feasible and acceptable to both providers and FP clients. The report also examines the socio-demographic profile of providers and clients, method continuation, and feasibility and acceptability of home self-injection. Results have informed the national scale-up of DMPA-SC in public and private facilities, which began in April 2019.
Nai, Dela, Patrick Aboagye, Kamil Fuseini, Elizabeth Tobey, Aparna Jain, Nora Maresh, and Rebecca Fertziger. 2020. "Introduction of DMPA-SC self-injection in Ghana: A feasibility and acceptability study using Sayana® Press," Research report. Washington, DC: Population Council, The Evidence Project.
The Evidence Project